Storys zum Thema Pharmaindustrie

News Direct

Q-VANT and In vitro Plant-tech Sign Agreement for the Development and Supply of Quillaja saponaria Plant Cell Culture Biomass

BOSTON, MA (ots) - --News Direct-- Q-VANT Biosciences, the first company to achieve a 100% sustainable way to meet the growing global vaccine market demand for Quillaja saponin-based adjuvants, today announced that it has signed an agreement with In vitro Plant-tech AB, a Swedish plant cell cultivation company whose ...

Sysmex Inostics GmbH

University of Chicago Clinical Trial Utilizes Sysmex Inostics Highly Effective HPV-SEQ Test to Measure HPV-DNA from Blood of Neck and Throat Cancer Patients

Baltimore, MD (ots) - Sysmex Inostics, a global leader in the liquid biopsy revolution for oncology, announces the use of their HPV-SEQ test in the prospective University of Chicago clinical trial,1 “Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer.” “The ability to reliably detect HPV-DNA ...

Technische Universität München

mRNA containing nanoparticles in the light of neutrons - investigations at FRM II aid in the development of mRNA medications

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37120 High resolution images: https://mediatum.ub.tum.de/1638436 NEWS RELEASE Optimization of mRNA ...

Brenntag SE

Brenntag’s Pharma section signs exclusive agreement for health-promoting product line Akovita ELIP in EMEA

benfovir AG

New therapeutic approach against SARS-CoV-2 successfully tested

Pfungstadt (ots) - - Scientists at the Universities of Frankfurt a.M. and Kent (UK) have identified a metabolic pathway (pentose-phosphate pathway) that is crucial for the propagation of the SARS-CoV-2 virus in human cells. - The compound benfo-oxythiamine, an inhibitor of this metabolic pathway, has succeeded in blocking the replication of the SARS-CoV-2 virus in human cells. - Preclinical testing of this compound has ...

4GENE GmbH

Cosmetics: Glucosides ensure increased bioavailability

C osmetics: Glucosides ensure increased bioavailability Glucosides eliminate the need for microplastics and provide increased bioavailability in cosmetic applications Freising/Germany, December 9, 2021 – Conventional active ingredients and fragrances in cosmetic products often evaporate shortly after application to the skin. Freising-based biotech company 4GENE has solved this problem by developing a special process ...

Almirall, S.A.

Almirall delivers solid nine months 2021 results and tightens its upgraded guidance

Barcelona, Spain (ots/PRNewswire) - - Strong Core business performance with growth in Core Net Sales EUR601.7 MM (+6.2% year-on-year) and Core EBITDA reaching EUR164.2 MM, (+20.3% year-on-year) driven by positive contribution from Growth Drivers and a strong EU dermatology performance - Key Growth Drivers underpinning increase in Core Net Sales. Strong performance from ...

Fördergesellschaft IZB mbH

2

The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics

LEUKOCARE AG

Dr. Dirk Winnemöller joins Leukocare as Vice President Commercial

Martinsried/Munich (ots) - Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, today announced that Dr. Dirk Winnemöller took up the newly established role as Vice President Commercial at Leukocare. Dirk joins the Company from Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany, where he served as Global Vice ...

eleva GmbH

Eleva Enters Clinical Development of Difficult-To-Express High-Potential Proteins

Freiburg (ots) - Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, as well as in collaboration with pharmaceutical partners. Its moss-based platform is ideally suited to produce difficult-to-express but therapeutically promising drug candidates. Its recently expanded production ...

Almirall, S.A.

Almirall S.A.: Experts highlight the need to focus on psoriasis patients' wellbeing in clinical practice

Barcelona, Spain (ots/PRNewswire) - - Psoriasis affects the overall emotional wellbeing of 88% of patients[1], and at least 20% of psoriasis patients have considered suicide[2] - Currently used endpoints in psoriasis do not capture the full impact of this skin condition on patients' lives, and almost 50% of them ...

eleva GmbH

Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H

Freiburg (ots) - Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases. Eleva has ordered four more state-of-the-art, 500 l single-use reactors from Sartorius Stedim Systems. The scale-up will enable Eleva to enter ...

Gold Standard Diagnostics Europe

Novatec and Virotech to become Gold Standard Diagnostics Europe

Dietzenbach (ots) - The two German diagnostics companies Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH are excited to announce that they have joined forces and will now operate together as Gold Standard Diagnostics Europe. Both entities have agreed to consolidate their businesses to better address their partners´ needs and demands. Since the SARS COV 2 outbreak, the companies have been committed to ...

Almirall, S.A.

Lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials

Barcelona (ots/PRNewswire) - - Primary and all key secondary endpoints including itch, interference of itch on sleep and quality of life were met at Week 16 in two pivotal Phase 3 trials - Safety profile consistent with prior lebrikizumab studies in atopic dermatitis Lebrikizumab led to significant improvements with ...

Dermago GmbH

ePresentation of the results of the in-vitro study regarding the anti-proliferative and pro-apoptotic effects of Polyphenon® E (Veregen®) at the 31st German Skin Cancer Congress on 10 September 2021

Strausberg (ots) - Aresus Pharma GmbH, a company of DERMAGO Holding GmbH, announced today that the abstract "Inhibition of cell-proliferation and cell viability by Polyphenon E ® (Veregen®) in cutaneous SCC cell lines" has been accepted as an e-poster short presentation at the 31st German Skin Cancer Congress. In ...

Semdor Pharma Group

Ansgar Eschkötter Joins Senior Management Team of the PS Group

Fördergesellschaft IZB mbH

2

COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant

Fördergesellschaft IZB mbH

7

Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021

Semdor Pharma Group

Semdor Pharma adds Global Pharmaceutical Executive Rolf Hoffmann to its Board of Directors

Cologne (ots) - 30-year pharma veteran Rolf Hoffmann, formerly senior global executive at Amgen and Eli Lilly, joins Semdor Pharma as investor and commercial expert. Semdor Pharma Group announced today that it has added Rolf Hoffmann, a seasoned global pharma executive and advisor, to its Board of Directors, as well as an investor in the company. Mr. Hoffmann ...

DAS Environmental Expert GmbH

German Green Technology from DAS Environmental Experts for Swiss DSM Nutritional Products AG / Moving Bed Biofilm Reactor for sustainable wastewater treatment for the food industry

Dresden (ots) - Increasing production capacities have stretched the existing wastewater treatment plant at the chemical company DSM Nutritional Products in Switzerland to its limits. Wastewater characteristics of the chemical industry with strict regulations of the beverage and food industry - the experts of German ...

Fördergesellschaft IZB mbH

Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins

European Association of E-Pharmacies (EAEP)

EAEP as a Driving Force and Think Tank: European Association of Online Pharmacies Repositions Itself

Brussels/Berlin (ots) - The leading association of European online pharmacies has a new board team, a new name and a new external image: Walter Hess, Head Germany in the Group Management of the Zur Rose Group and CEO of DocMorris N.V., is now president of the association and Stefan Feltens, CEO SHOP APOTHEKE EUROPE, ...

Fördergesellschaft IZB mbH

3

World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools

Semdor Pharma Group

Merger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis